Clinical Trial

Evaluate the Safety and Efficacy of HDM1002 Tablets in Chinese Overweight and Obese Adults

Name: Evaluate the Safety and Efficacy of HDM1002 Tablets in Chinese Overweight and Obese Adults — clinical trial record (NCT06885021)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Record status

This record was last updated March 19, 2025 (before its estimated May 30, 2026 completion). Its status may not reflect the trial's current state.

Summary

A Phase 3 Trial to Evaluate the Safety and Efficacy of HDM1002 Tablets in Overweight and Obese Adults

Trial Details

NCT Number	NCT06885021
Lead Sponsor	Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Conditions	Overweight and Obesity
Enrollment	780 participants
Start Date	2025-03-28
Primary Completion	2026-05-30 (estimated)
Study Completion	2026-06-30 (estimated)
Updated on ClinicalTrials.gov	2025-03-19